
Inorganica Chimica Acta p. 2758 - 2766 (2007)
Update date:2022-07-29
Topics:
Fu, Wen-Fu
Gan, Xin
Jiao, Jian
Chen, Yong
Yuan, Mei
Chi, Shao-Ming
Yu, Ming-Ming
Xiong, Shao-Xiang
The reaction of [Cu(CH3CN)4]BF4, 6-(4-methoxyl)phenyl-2,2′-bipyridine (designated as MeO-CNN), and/or tricyclohexylphosphine (PCy3) and diimine ligands derived from 4,4′-bipyridine gave four mono- and binuclear copper(I) complexes, [Cu(MeO-CNN)2]BF4 (1), [Cu2(MeO-CNN)2(PCy3)2(4,4′-bipy)](BF4)2 · 1.5CH2Cl2 (2) (bipy = bipyridine), [Cu2(MeO-CNN)2(PCy3)2(bpete)](BF4)2 · 4CH2Cl2 (3) (bpete = trans-1,2-bis(4-pyridyl)ethene) and [Cu2(MeO-CNN)2(PCy3)2(4,4′-azpy)] (BF4)2 · 1.5CH2Cl2 (4) (azpy = azobispyridine). Crystallographic studies of complexes 1-4 show that each copper(I) center adopts a pseudo-tetrahedral coordination geometry. Complexes 2-4 consists of -Cu(MeO-CNN)(PCy3) units which are linked through 4,4′-bipy, bpete and 4,4′-azpy, respectively. The UV-Vis spectra of these four complexes all exhibit intense high-energy absorptions at λmax < 340 nm and broad visible bands in a range of 430-550 nm, ascribed to intraligand (IL π → π*) transitions and metal-to-ligand charge-transfer (MLCT) transitions, respectively. The density functional theory calculation was used to interpret the absorption spectrum of 1, which further supports the assignment of MLCT character. The binuclear complexes 2 and 3 both display red solid-state emissions centred at 620 and 660 nm from metal-to-ligand charge-transfer excited state, respectively. Interestingly, the electron paramagnetic resonance (EPR) spectral measurements confirm copper(I) complexes oxidized to corresponding copper(II)-halide product upon excitation at 355 nm in dichloromethane solution.
Contact:852-27701081
Address:Room 2509, New Tech Plaza, 34 Tai Yau St., San Po Kong, HK
Yantai Derun Liquid Crystal Materials Co. Ltd.
website:http://www.ytderun.com
Contact:86-535-6300169
Address:ROOM 90, XIANGFU STREET, FUSHAN NEW-HIGH-TECH IDUSTRY ZONE, YANTAI
VanderArk International Limited
Contact:86-10-82437576
Address:Qing He
Angelisun(Chongqing) Pharmaceutical Co., LTD.
Contact:+86-23-68030926-816
Address:D1-7 Tech & Entrepreneurs Park, Kecheng Road, Erlang Hi-Tech Areas, Chongqing, China
Contact:86-25-84683399
Address:605, Phoenix Herui Plaza, No.389, South Taiping Road, Nanjing, China 210002
Doi:10.1055/s-2005-861783
(2005)Doi:10.1039/c0ob00475h
(2011)Doi:10.1021/acs.orglett.1c02379
(2021)Doi:10.1021/ja042849b
(2005)Doi:10.1039/b500419e
(2005)Doi:10.1007/BF00950664
(1982)